While this type of cancer was only found in rodent studies (not in humans), people who have a personal or family history of thyroid cancer, including medullary thyroid carcinoma (MTC), or MEN2 syndrome shouldn't take GLP-1 medications like Mounjaro or Ozempic
Local Injection for Back Injuries: Why abdominal sub-q still works systemically and how BPC + TB-500 rebuild connective tissue post-dislocation When to Start TRT & HGH Mid Weight Loss Journey: Why 51 with 35 pounds already lost is the perfect time and how to wean Retatrutide down the right way Subscribe for weekly, no-fluff protocols, dosing guidance, and real-world results
Important factors affecting GLP-1 market demand and take-up include: The need for better long-term data on the safety and efficacy of use for the designated indications The rapidly expanding list of potential new indications for the drugs, including chronic kidney disease, broader cardiovascular risk reduction, metabolic liver disease, and Alzheimer's disease The number of similar drugs in the development pipeline Price point versus competition, which affects affordability and insurance coverage Marketing efforts of the manufacturers, supply and distribution constraints
We waited until 2025because thats when we felt the clinical evidence was clear